---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-102812"
form_type: "8-K"
ticker: "ELUT"
cik: "0001708527"
company_name: "ELUTIA INC."
filed_at: "2023-09-21T23:59:59+00:00"
generated_at: "2026-06-10T10:50:30.291251+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Elutia raises $10.5M in PIPE with up to $26.2M from warrants; plus divestiture >$60M total cash

## Summary
- Initial gross proceeds ~$10.5M from sale of 7.36M shares/pre-funded warrants and 11.03M common warrants.
- Full exercise of warrants would add $15.8M, bringing total PIPE proceeds to $26.2M.
- Combined with Orthobiologics divestiture (announced Sep 18), total cash added >$60M.
- Warrants exercisable at $1.4275 until 30 trading days post-FDA clearance of CanGarooRM or 5 years.
- Investors include existing HighCape Capital, new Nantahala Capital, and a life-sciences fund.

## SEC filing metadata
- accession: 0001104659-23-102812
- form_type: 8-K
- ticker: ELUT
- cik: 0001708527
- company_name: ELUTIA INC.
- filed_at: 2023-09-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708527/000110465923102812/0001104659-23-102812-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708527/000110465923102812/tm2326577d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-102812
- JSON: https://secwatch.observer/filing/0001104659-23-102812.json
- Plain text: https://secwatch.observer/filing/0001104659-23-102812.txt

## Key facts
- Material Agreements
  ELUTIA INC. entered into Securities Purchase Agreement with purchasers named therein valued at aggregate gross proceeds of approximately $10.5 million (effective 2023-09-18).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: purchasers named therein
  - Value: aggregate gross proceeds of approximately $10.5 million
  - Effective: 2023-09-18
  source text: On September 18, 2023, Elutia Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers named therein (the “Investors”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708527/000110465923102812/0001104659-23-102812-index.htm
- Material Agreements
  ELUTIA INC. entered into Registration Rights Agreement with purchasers named therein valued at Company agreed to prepare and file a registration statement within 60 days after closing (effective 2023-09-21).
  - Action: entry
  - Counterparty: purchasers named therein
  - Value: Company agreed to prepare and file a registration statement within 60 days after closing
  - Effective: 2023-09-21
  source text: On September 21, 2023, in connection with the closing of the Offering, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Investors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708527/000110465923102812/0001104659-23-102812-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.